Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,455
Closed -$210K 226
2020
Q2
$210K Sell
3,455
-243
-7% -$15K 0.02% 180
2020
Q1
$203K Sell
3,698
-109
-3% -$7.31K 0.03% 171
2019
Q4
$275K Sell
3,807
-32
-0.8% -$2.18K 0.03% 163
2019
Q3
$254K Buy
+3,839
New +$247K 0.03% 157
2018
Q3
Sell
-3,714
Closed -$246K 198
2018
Q2
$246K Sell
3,714
-550
-13% -$37K 0.03% 144
2018
Q1
$284K Sell
4,264
-260
-6% -$17.5K 0.04% 133
2017
Q4
$296K Sell
4,524
-1,476
-25% -$95.8K 0.04% 137
2017
Q3
$386K Buy
6,000
+59
+1% +$3.81K 0.06% 115
2017
Q2
$383K Hold
5,941
0.08% 106
2017
Q1
$362K Buy
5,941
+7
+0.1% +$421 0.07% 110
2016
Q4
$346K Buy
5,934
+33
+0.6% +$1.95K 0.08% 109
2016
Q3
$341K Buy
+5,901
New +$348K 0.13% 97

Other funds holding DOX

Keel Point's DOX Position: Q3 2020 in Review

Keel Point sold out of Amdocs (DOX) in Q3 2020, closing a stake of 3,455 shares — an estimated $210K sold.

Keel Point first reported a position in DOX in Q3 2016 and held it in 12 quarters. The position peaked at $386K in Q3 2017. 395 funds tracked by Wall St. Rank hold DOX as of Q3 2020.

  • Keel Point reported no remaining Amdocs position as of Q3 2020 after selling out during the quarter.
  • Keel Point sold 3,455 Amdocs shares in Q3 2020, an estimated $210K.
  • Keel Point first reported a position in Amdocs in Q3 2016 and held it in 12 quarters.
  • Keel Point's Amdocs position peaked at $386K in Q3 2017.
  • 395 funds tracked by Wall St. Rank held Amdocs as of Q3 2020.

Based on Keel Point's 13F filing for Q3 2020, filed 18 Nov 2020.